-The Hindu In what is regarded as a major administrative move, the Planning Commission has cleared the transfer of the Pradhan Mantri Adarsh Gram Yojana(PMAGY) to the Ministry of Rural Development (MoRD) from the Ministry of Social Justice and Empowerment. Planning Commission Deputy Chairman Montek Singh Ahluwalia has conveyed the in principle approval of transfer of the scheme to Rural Development Minister Jairam Ramesh saying that the PMAGY had a synergy with...

-The Hindu The State Information Commission agreed to consider some of the demands of the RTI Kerala Federation and other organisations that staged a dharna before the commission here on Tuesday. In talks with leaders of the organisations, Chief Information Commissioner Siby Mathews said the commission would consider their representation against delegation of its powers regarding disposal of petitions to officials. The commission had been returning complaints recently, on grounds that first appeals...

-The Hindu As it stands on the threshold of the Twelfth Plan, India has a historic opportunity to elevate education and healthcare as the strongest PILlars of its future development. Yearning for life-building education is unprecedented today. Yet, as Amartya Sen pointed out last year, the system remains deeply unjust. Access to excellence is open to those who can afford it, while the less-affluent majority has been left behind without even...

Bowing to the clamour for scrutiny of the accounts of private power distribution companies operating in the city, the Delhi government has finally approved their audit by the Comptroller and Auditor General (CAG). According to a cabinet note, the government sanctioned an audit of the three discoms — BSES Yamuna and Rajdhani, and NDPL — “since inception.” The decision to get a CAG audit carried out was disclosed during a hearing in...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...